Physician

William James, DO

According to 2025 Medicare claims, William James, DO (NPI: 1851754865) practices family practice in the Traverse City, MI market, with the plurality of this provider's patient population coming from Benzie, MI. This provider's primary affiliated billing organization is CRYSTAL LAKE CLINIC P.C. (NPI: 1316991755; TIN: 383052737) and primary practice location at 49616-8633. James is affiliated with the West Michigan Accountable Care Organization, LLC (ACO ID: A4626) and Honest MSSP of Michigan LLC (ACO ID: A5616), participating under the MSSP model.

James' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 602 traditional Medicare patients, billed 2,352 HCPCS/CPT codes, and received $133,917 in Medicare payments. The top billing code was G0439 (Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit). Part D data shows 6,001 prescription claims across 603 beneficiaries totaling $724,615 in drug costs, led by Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter). DME data shows 127 claims. Open Payments data shows 59 records totaling $1,184. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $4,775 to $724,615. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	68	106	$7,438
2022	582	2,035	$133,540
2023	648	2,624	$183,860
2024	602	2,352	$133,917

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	11	36	$4,775
2019	39	169	$24,055
2020	50	358	$63,324
2021	94	561	$66,629
2022	479	3,492	$319,417
2023	546	5,743	$702,870
2024	603	6,001	$724,615

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	65	$3,504
2024	N/R	127	$28,628

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
G0439	Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit	191	191	$112
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	359	726	$70
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	288	444	$48
87426	Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus	53	56	$34
83036	Hemoglobin a1c level	70	147	$9

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	135	5,220	$109,581
Jardiance	Empagliflozin	79	4,431	$84,445
Eliquis	Apixaban	89	4,207	$75,495
Ozempic	Semaglutide	44	1,442	$42,916
Xarelto	Rivaroxaban	49	2,250	$40,121

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J7677	Revefenacin inhalation solution, fda-approved final product, non-compounded, administered through dme, 1 microgram	N	N/R	17	$12,945
E0466	Home ventilator, any type, used with non-invasive interface, (e.g., mask, chest shell)	Y	N/R	12	$12,065
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	18	$1,502
J7626	Budesonide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, up to 0.5 mg	N	N/R	18	$915
Q0513	Pharmacy dispensing fee for inhalation drug(s); per 30 days	N	N/R	21	$543

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	59	$1,184	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for William James, DO?

Tedicare shows public-source Medicare data for William James, DO (NPI 1851754865), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does William James, DO have ACO affiliation data?

William James, DO is shown with ACO affiliation data for West Michigan Accountable Care Organization, LLC (MSSP, ACO ID A4626) and Honest MSSP of Michigan LLC (MSSP, ACO ID A5616).

What billing organization is linked to William James, DO?

William James, DO is linked to CRYSTAL LAKE CLINIC P.C. (billing NPI 1316991755) in the available physician profile data.

Does William James, DO have Open Payments data?

William James, DO has 59 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.